ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Afatinib API Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-16L18060
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Afatinib API Market Research Report 2024
BUY CHAPTERS

Global Afatinib API Market Research Report 2026

Code: QYRE-Auto-16L18060
Report
2026-02-13
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shandong Anhong Pharmaceutical
Lianyungang Runzhong Pharmaceutical
Jiangsu Tasly Diyi Pharmaceutical
Fresenius Kabi
Shilpa Medicare
Clearsynth Labs
MSN Laboratories
Hetero Labs
Alembic Pharmaceuticals
Lotus International
Caplin Point Laboratories
Rmpl Pharma Llp
Jiangsu Xidi Pharmaceuticals

Afatinib API Market

The global Afatinib API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Afatinib API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Afatinib is an Active Pharmaceutical Ingredient (API) that serves as a selective, irreversible tyrosine kinase inhibitor used in cancer therapy. It is primarily indicated for the treatment of advanced non-small cell lung cancer with specific genetic mutations in the epidermal growth factor receptor (EGFR) gene.
The North American market for Afatinib API is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Afatinib API is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Afatinib API include Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, Shilpa Medicare, Clearsynth Labs, MSN Laboratories, Hetero Labs, Alembic Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Afatinib API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Afatinib API. The Afatinib API market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Afatinib API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Afatinib API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Afatinib API Market Report

Report Metric Details
Report Name Afatinib API Market
Segment by Type
  • Purity≥99%
  • Purity<99%
by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, Shilpa Medicare, Clearsynth Labs, MSN Laboratories, Hetero Labs, Alembic Pharmaceuticals, Lotus International, Caplin Point Laboratories, Rmpl Pharma LLP
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Afatinib API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Afatinib API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Afatinib API Market report?

Ans: The main players in the Afatinib API Market are Shandong Anhong Pharmaceutical, Lianyungang Runzhong Pharmaceutical, Jiangsu Xidi Pharmaceuticals, Jiangsu Tasly Diyi Pharmaceutical, Fresenius Kabi, Shilpa Medicare, Clearsynth Labs, MSN Laboratories, Hetero Labs, Alembic Pharmaceuticals, Lotus International, Caplin Point Laboratories, Rmpl Pharma LLP

What are the Application segmentation covered in the Afatinib API Market report?

Ans: The Applications covered in the Afatinib API Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Afatinib API Market report?

Ans: The Types covered in the Afatinib API Market report are Purity≥99%, Purity<99%

1 Afatinib API Market Overview
1.1 Product Definition
1.2 Afatinib API by Type
1.2.1 Global Afatinib API Market Value by Type: 2025 vs 2032
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Afatinib API by Application
1.3.1 Global Afatinib API Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Afatinib API Market Size Estimates and Forecasts
1.4.1 Global Afatinib API Revenue 2021–2032
1.4.2 Global Afatinib API Sales 2021–2032
1.4.3 Global Afatinib API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Afatinib API Market Competition by Manufacturers
2.1 Global Afatinib API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Afatinib API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Afatinib API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Afatinib API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Afatinib API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Afatinib API, Product Types and Applications
2.7 Global Key Manufacturers of Afatinib API, Date of Entry into the Industry
2.8 Global Afatinib API Market Competitive Situation and Trends
2.8.1 Global Afatinib API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Afatinib API Players Market Share by Revenue
2.8.3 Global Afatinib API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Afatinib API Market Scenario by Region
3.1 Global Afatinib API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Afatinib API Sales by Region: 2021–2032
3.2.1 Global Afatinib API Sales by Region: 2021–2026
3.2.2 Global Afatinib API Sales by Region: 2027–2032
3.3 Global Afatinib API Revenue by Region: 2021–2032
3.3.1 Global Afatinib API Revenue by Region: 2021–2026
3.3.2 Global Afatinib API Revenue by Region: 2027–2032
3.4 North America Afatinib API Market Facts & Figures by Country
3.4.1 North America Afatinib API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Afatinib API Sales by Country (2021–2032)
3.4.3 North America Afatinib API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Afatinib API Market Facts & Figures by Country
3.5.1 Europe Afatinib API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Afatinib API Sales by Country (2021–2032)
3.5.3 Europe Afatinib API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Afatinib API Market Facts & Figures by Region
3.6.1 Asia Pacific Afatinib API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Afatinib API Sales by Region (2021–2032)
3.6.3 Asia Pacific Afatinib API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Afatinib API Market Facts & Figures by Country
3.7.1 Latin America Afatinib API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Afatinib API Sales by Country (2021–2032)
3.7.3 Latin America Afatinib API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Afatinib API Market Facts & Figures by Country
3.8.1 Middle East and Africa Afatinib API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Afatinib API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Afatinib API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Afatinib API Sales by Type (2021–2032)
4.1.1 Global Afatinib API Sales by Type (2021–2026)
4.1.2 Global Afatinib API Sales by Type (2027–2032)
4.1.3 Global Afatinib API Sales Market Share by Type (2021–2032)
4.2 Global Afatinib API Revenue by Type (2021–2032)
4.2.1 Global Afatinib API Revenue by Type (2021–2026)
4.2.2 Global Afatinib API Revenue by Type (2027–2032)
4.2.3 Global Afatinib API Revenue Market Share by Type (2021–2032)
4.3 Global Afatinib API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Afatinib API Sales by Application (2021–2032)
5.1.1 Global Afatinib API Sales by Application (2021–2026)
5.1.2 Global Afatinib API Sales by Application (2027–2032)
5.1.3 Global Afatinib API Sales Market Share by Application (2021–2032)
5.2 Global Afatinib API Revenue by Application (2021–2032)
5.2.1 Global Afatinib API Revenue by Application (2021–2026)
5.2.2 Global Afatinib API Revenue by Application (2027–2032)
5.2.3 Global Afatinib API Revenue Market Share by Application (2021–2032)
5.3 Global Afatinib API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shandong Anhong Pharmaceutical
6.1.1 Shandong Anhong Pharmaceutical Company Information
6.1.2 Shandong Anhong Pharmaceutical Description and Business Overview
6.1.3 Shandong Anhong Pharmaceutical Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shandong Anhong Pharmaceutical Afatinib API Product Portfolio
6.1.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
6.2 Lianyungang Runzhong Pharmaceutical
6.2.1 Lianyungang Runzhong Pharmaceutical Company Information
6.2.2 Lianyungang Runzhong Pharmaceutical Description and Business Overview
6.2.3 Lianyungang Runzhong Pharmaceutical Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lianyungang Runzhong Pharmaceutical Afatinib API Product Portfolio
6.2.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
6.3 Jiangsu Xidi Pharmaceuticals
6.3.1 Jiangsu Xidi Pharmaceuticals Company Information
6.3.2 Jiangsu Xidi Pharmaceuticals Description and Business Overview
6.3.3 Jiangsu Xidi Pharmaceuticals Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Jiangsu Xidi Pharmaceuticals Afatinib API Product Portfolio
6.3.5 Jiangsu Xidi Pharmaceuticals Recent Developments/Updates
6.4 Jiangsu Tasly Diyi Pharmaceutical
6.4.1 Jiangsu Tasly Diyi Pharmaceutical Company Information
6.4.2 Jiangsu Tasly Diyi Pharmaceutical Description and Business Overview
6.4.3 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jiangsu Tasly Diyi Pharmaceutical Afatinib API Product Portfolio
6.4.5 Jiangsu Tasly Diyi Pharmaceutical Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Company Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Kabi Afatinib API Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Shilpa Medicare
6.6.1 Shilpa Medicare Company Information
6.6.2 Shilpa Medicare Description and Business Overview
6.6.3 Shilpa Medicare Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shilpa Medicare Afatinib API Product Portfolio
6.6.5 Shilpa Medicare Recent Developments/Updates
6.7 Clearsynth Labs
6.7.1 Clearsynth Labs Company Information
6.7.2 Clearsynth Labs Description and Business Overview
6.7.3 Clearsynth Labs Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Clearsynth Labs Afatinib API Product Portfolio
6.7.5 Clearsynth Labs Recent Developments/Updates
6.8 MSN Laboratories
6.8.1 MSN Laboratories Company Information
6.8.2 MSN Laboratories Description and Business Overview
6.8.3 MSN Laboratories Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 MSN Laboratories Afatinib API Product Portfolio
6.8.5 MSN Laboratories Recent Developments/Updates
6.9 Hetero Labs
6.9.1 Hetero Labs Company Information
6.9.2 Hetero Labs Description and Business Overview
6.9.3 Hetero Labs Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hetero Labs Afatinib API Product Portfolio
6.9.5 Hetero Labs Recent Developments/Updates
6.10 Alembic Pharmaceuticals
6.10.1 Alembic Pharmaceuticals Company Information
6.10.2 Alembic Pharmaceuticals Description and Business Overview
6.10.3 Alembic Pharmaceuticals Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Alembic Pharmaceuticals Afatinib API Product Portfolio
6.10.5 Alembic Pharmaceuticals Recent Developments/Updates
6.11 Lotus International
6.11.1 Lotus International Company Information
6.11.2 Lotus International Description and Business Overview
6.11.3 Lotus International Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Lotus International Afatinib API Product Portfolio
6.11.5 Lotus International Recent Developments/Updates
6.12 Caplin Point Laboratories
6.12.1 Caplin Point Laboratories Company Information
6.12.2 Caplin Point Laboratories Description and Business Overview
6.12.3 Caplin Point Laboratories Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Caplin Point Laboratories Afatinib API Product Portfolio
6.12.5 Caplin Point Laboratories Recent Developments/Updates
6.13 Rmpl Pharma LLP
6.13.1 Rmpl Pharma LLP Company Information
6.13.2 Rmpl Pharma LLP Description and Business Overview
6.13.3 Rmpl Pharma LLP Afatinib API Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Rmpl Pharma LLP Afatinib API Product Portfolio
6.13.5 Rmpl Pharma LLP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Afatinib API Industry Chain Analysis
7.2 Afatinib API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Afatinib API Production Mode & Process Analysis
7.4 Afatinib API Sales and Marketing
7.4.1 Afatinib API Sales Channels
7.4.2 Afatinib API Distributors
7.5 Afatinib API Customer Analysis
8 Afatinib API Market Dynamics
8.1 Afatinib API Industry Trends
8.2 Afatinib API Market Drivers
8.3 Afatinib API Market Challenges
8.4 Afatinib API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shandong Anhong Pharmaceutical
Lianyungang Runzhong Pharmaceutical
Jiangsu Tasly Diyi Pharmaceutical
Fresenius Kabi
Shilpa Medicare
Clearsynth Labs
MSN Laboratories
Hetero Labs
Alembic Pharmaceuticals
Lotus International
Caplin Point Laboratories
Rmpl Pharma Llp
Jiangsu Xidi Pharmaceuticals
List of Tables
 Table 1. Global Afatinib API Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Afatinib API Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Afatinib API Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Afatinib API Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Afatinib API Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Afatinib API Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Afatinib API Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Afatinib API Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Afatinib API, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Afatinib API, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Afatinib API, Product Types and Applications
 Table 12. Global Key Manufacturers of Afatinib API, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Afatinib API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Afatinib API Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Afatinib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Afatinib API Sales by Region (Tons), 2021–2026
 Table 18. Global Afatinib API Sales Market Share by Region (2021–2026)
 Table 19. Global Afatinib API Sales by Region (Tons), 2027–2032
 Table 20. Global Afatinib API Sales Market Share by Region (2027–2032)
 Table 21. Global Afatinib API Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Afatinib API Revenue Market Share by Region (2021–2026)
 Table 23. Global Afatinib API Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Afatinib API Revenue Market Share by Region (2027–2032)
 Table 25. North America Afatinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Afatinib API Sales by Country (Tons), 2021–2026
 Table 27. North America Afatinib API Sales by Country (Tons), 2027–2032
 Table 28. North America Afatinib API Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Afatinib API Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Afatinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Afatinib API Sales by Country (Tons), 2021–2026
 Table 32. Europe Afatinib API Sales by Country (Tons), 2027–2032
 Table 33. Europe Afatinib API Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Afatinib API Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Afatinib API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Afatinib API Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Afatinib API Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Afatinib API Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Afatinib API Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Afatinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Afatinib API Sales by Country (Tons), 2021–2026
 Table 42. Latin America Afatinib API Sales by Country (Tons), 2027–2032
 Table 43. Latin America Afatinib API Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Afatinib API Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Afatinib API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Afatinib API Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Afatinib API Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Afatinib API Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Afatinib API Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Afatinib API Sales (Tons) by Type (2021–2026)
 Table 51. Global Afatinib API Sales (Tons) by Type (2027–2032)
 Table 52. Global Afatinib API Sales Market Share by Type (2021–2026)
 Table 53. Global Afatinib API Sales Market Share by Type (2027–2032)
 Table 54. Global Afatinib API Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Afatinib API Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Afatinib API Revenue Market Share by Type (2021–2026)
 Table 57. Global Afatinib API Revenue Market Share by Type (2027–2032)
 Table 58. Global Afatinib API Price (US$/kg) by Type (2021–2026)
 Table 59. Global Afatinib API Price (US$/kg) by Type (2027–2032)
 Table 60. Global Afatinib API Sales (Tons) by Application (2021–2026)
 Table 61. Global Afatinib API Sales (Tons) by Application (2027–2032)
 Table 62. Global Afatinib API Sales Market Share by Application (2021–2026)
 Table 63. Global Afatinib API Sales Market Share by Application (2027–2032)
 Table 64. Global Afatinib API Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Afatinib API Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Afatinib API Revenue Market Share by Application (2021–2026)
 Table 67. Global Afatinib API Revenue Market Share by Application (2027–2032)
 Table 68. Global Afatinib API Price (US$/kg) by Application (2021–2026)
 Table 69. Global Afatinib API Price (US$/kg) by Application (2027–2032)
 Table 70. Shandong Anhong Pharmaceutical Company Information
 Table 71. Shandong Anhong Pharmaceutical Description and Business Overview
 Table 72. Shandong Anhong Pharmaceutical Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Shandong Anhong Pharmaceutical Afatinib API Product
 Table 74. Shandong Anhong Pharmaceutical Recent Developments/Updates
 Table 75. Lianyungang Runzhong Pharmaceutical Company Information
 Table 76. Lianyungang Runzhong Pharmaceutical Description and Business Overview
 Table 77. Lianyungang Runzhong Pharmaceutical Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Lianyungang Runzhong Pharmaceutical Afatinib API Product
 Table 79. Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
 Table 80. Jiangsu Xidi Pharmaceuticals Company Information
 Table 81. Jiangsu Xidi Pharmaceuticals Description and Business Overview
 Table 82. Jiangsu Xidi Pharmaceuticals Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Jiangsu Xidi Pharmaceuticals Afatinib API Product
 Table 84. Jiangsu Xidi Pharmaceuticals Recent Developments/Updates
 Table 85. Jiangsu Tasly Diyi Pharmaceutical Company Information
 Table 86. Jiangsu Tasly Diyi Pharmaceutical Description and Business Overview
 Table 87. Jiangsu Tasly Diyi Pharmaceutical Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Jiangsu Tasly Diyi Pharmaceutical Afatinib API Product
 Table 89. Jiangsu Tasly Diyi Pharmaceutical Recent Developments/Updates
 Table 90. Fresenius Kabi Company Information
 Table 91. Fresenius Kabi Description and Business Overview
 Table 92. Fresenius Kabi Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Fresenius Kabi Afatinib API Product
 Table 94. Fresenius Kabi Recent Developments/Updates
 Table 95. Shilpa Medicare Company Information
 Table 96. Shilpa Medicare Description and Business Overview
 Table 97. Shilpa Medicare Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Shilpa Medicare Afatinib API Product
 Table 99. Shilpa Medicare Recent Developments/Updates
 Table 100. Clearsynth Labs Company Information
 Table 101. Clearsynth Labs Description and Business Overview
 Table 102. Clearsynth Labs Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Clearsynth Labs Afatinib API Product
 Table 104. Clearsynth Labs Recent Developments/Updates
 Table 105. MSN Laboratories Company Information
 Table 106. MSN Laboratories Description and Business Overview
 Table 107. MSN Laboratories Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. MSN Laboratories Afatinib API Product
 Table 109. MSN Laboratories Recent Developments/Updates
 Table 110. Hetero Labs Company Information
 Table 111. Hetero Labs Description and Business Overview
 Table 112. Hetero Labs Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. Hetero Labs Afatinib API Product
 Table 114. Hetero Labs Recent Developments/Updates
 Table 115. Alembic Pharmaceuticals Company Information
 Table 116. Alembic Pharmaceuticals Description and Business Overview
 Table 117. Alembic Pharmaceuticals Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Alembic Pharmaceuticals Afatinib API Product
 Table 119. Alembic Pharmaceuticals Recent Developments/Updates
 Table 120. Lotus International Company Information
 Table 121. Lotus International Description and Business Overview
 Table 122. Lotus International Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. Lotus International Afatinib API Product
 Table 124. Lotus International Recent Developments/Updates
 Table 125. Caplin Point Laboratories Company Information
 Table 126. Caplin Point Laboratories Description and Business Overview
 Table 127. Caplin Point Laboratories Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. Caplin Point Laboratories Afatinib API Product
 Table 129. Caplin Point Laboratories Recent Developments/Updates
 Table 130. Rmpl Pharma LLP Company Information
 Table 131. Rmpl Pharma LLP Description and Business Overview
 Table 132. Rmpl Pharma LLP Afatinib API Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 133. Rmpl Pharma LLP Afatinib API Product
 Table 134. Rmpl Pharma LLP Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Afatinib API Distributors List
 Table 138. Afatinib API Customers List
 Table 139. Afatinib API Market Trends
 Table 140. Afatinib API Market Drivers
 Table 141. Afatinib API Market Challenges
 Table 142. Afatinib API Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Afatinib API
 Figure 2. Global Afatinib API Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Afatinib API Market Share by Type: 2025 & 2032
 Figure 4. Purity≥99% Product Picture
 Figure 5. Purity<99% Product Picture
 Figure 6. Global Afatinib API Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Afatinib API Market Share by Application: 2025 & 2032
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Afatinib API Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Afatinib API Market Size (US$ Million), 2021–2032
 Figure 12. Global Afatinib API Sales (Tons), 2021–2032
 Figure 13. Global Afatinib API Average Price (US$/kg), 2021–2032
 Figure 14. Afatinib API Report Years Considered
 Figure 15. Afatinib API Sales Share by Manufacturers in 2025
 Figure 16. Global Afatinib API Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Afatinib API Players: Market Share by Revenue in Afatinib API in 2025
 Figure 18. Afatinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Afatinib API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Afatinib API Sales Market Share by Country (2021–2032)
 Figure 21. North America Afatinib API Revenue Market Share by Country (2021–2032)
 Figure 22. United States Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Afatinib API Sales Market Share by Country (2021–2032)
 Figure 25. Europe Afatinib API Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Afatinib API Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Afatinib API Revenue Market Share by Region (2021–2032)
 Figure 33. China Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Southeast Asia Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Latin America Afatinib API Sales Market Share by Country (2021–2032)
 Figure 41. Latin America Afatinib API Revenue Market Share by Country (2021–2032)
 Figure 42. Mexico Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Brazil Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Argentina Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Colombia Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Middle East and Africa Afatinib API Sales Market Share by Country (2021–2032)
 Figure 47. Middle East and Africa Afatinib API Revenue Market Share by Country (2021–2032)
 Figure 48. Turkey Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. UAE Afatinib API Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Global Sales Market Share of Afatinib API by Type (2021–2032)
 Figure 52. Global Revenue Market Share of Afatinib API by Type (2021–2032)
 Figure 53. Global Afatinib API Price (US$/kg) by Type (2021–2032)
 Figure 54. Global Sales Market Share of Afatinib API by Application (2021–2032)
 Figure 55. Global Revenue Market Share of Afatinib API by Application (2021–2032)
 Figure 56. Global Afatinib API Price (US$/kg) by Application (2021–2032)
 Figure 57. Afatinib API Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Icotinib API Market Research Report 2024
Global Brigatinib API Market Research Report 2024
Global Ceritinib API Market Research Report 2024
Global Crizotinib API Market Research Report 2024
Global Oncology API Market Research Report 2024
Global Gilteritinib API Market Research Report 2024
Global Afatinib Market Research Report 2024
Global Afatinib Dimaleate Market Research Report 2024
Sorafenib Tosylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dacomitinib API Market Research Report 2024
Global Gefitinib API Market Research Report 2024
Bosutinib API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Alectinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Saracatinib Market Research Report 2024
Global Dasatinib API Market Research Report 2024
Global EGFR TKI for Advanced NSCLC Market Research Report 2024
Global Midostaurin API Market Research Report 2024
Global Savolitinib Tablets Market Research Report 2024
Imatinib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EGFR TKI Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions